O
MJN

OppenheimerFunds’s Mead Johnson Nutrition Company MJN Stock Holding History

OppenheimerFunds’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,307
Closed -$1.63M – 1927
2017
Q1 		$1.63M Buy
18,307
+12,378
+209% +$1.02M ﹤0.01% 1006
2016
Q4 		$420K Buy
5,929
+1,004
+20% +$74.8K ﹤0.01% 1456
2016
Q3 		$389K Buy
4,925
+295
+6% +$25.2K ﹤0.01% 1381
2016
Q2 		$420K Sell
4,630
-55
-1% -$4.66K ﹤0.01% 1312
2016
Q1 		$398K Sell
4,685
-12
-0.3% -$893 ﹤0.01% 1315
2015
Q4 		$372K Buy
+4,697
New +$370K ﹤0.01% 1420
2015
Q2 		– Sell
-154,350
Closed -$15.5M – 990
2015
Q1 		$15.5M Buy
154,350
+7,830
+5% +$790K 0.02% 652
2014
Q4 		$14.7M Buy
146,520
+46,370
+46% +$4.62M 0.02% 666
2014
Q3 		$9.64M Buy
+100,150
New +$9.49M 0.01% 748
2013
Q3 		– Sell
-1,053,990
Closed -$83.5M – 979
2013
Q2 		$83.5M Buy
+1,053,990
New +$84.5M 0.12% 213

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

OppenheimerFunds's MJN Position: Q2 2017 in Review

OppenheimerFunds sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 18,307 shares — an estimated $1.63M sold.

OppenheimerFunds first reported a position in MJN in Q2 2013 and held it in 10 quarters. The position peaked at $83.5M in Q2 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • OppenheimerFunds reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • OppenheimerFunds sold 18,307 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.63M.
  • OppenheimerFunds first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 10 quarters.
  • OppenheimerFunds's Mead Johnson Nutrition Company position peaked at $83.5M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on OppenheimerFunds's 13F filing for Q2 2017, filed 14 Aug 2017.